BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31797602)

  • 1. DNA Repair Footprint Uncovers Contribution of DNA Repair Mechanism to Mutational Signatures.
    Wojtowicz D; Leiserson MDM; Sharan R; Przytycka TM
    Pac Symp Biocomput; 2020; 25():262-273. PubMed ID: 31797602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RepairSig: Deconvolution of DNA damage and repair contributions to the mutational landscape of cancer.
    Wojtowicz D; Hoinka J; Amgalan B; Kim YA; Przytycka TM
    Cell Syst; 2021 Oct; 12(10):994-1003.e4. PubMed ID: 34375586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-cancer association of DNA repair deficiencies with whole-genome mutational patterns.
    Sørensen SG; Shrikhande A; Poulsgaard GA; Christensen MH; Bertl J; Laursen BE; Hoffmann ER; Pedersen JS
    Elife; 2023 Mar; 12():. PubMed ID: 36883553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network-based approaches elucidate differences within APOBEC and clock-like signatures in breast cancer.
    Kim YA; Wojtowicz D; Sarto Basso R; Sason I; Robinson W; Hochbaum DS; Leiserson MDM; Sharan R; Vadin F; Przytycka TM
    Genome Med; 2020 May; 12(1):52. PubMed ID: 32471470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental systems for the analysis of mutational signatures: no 'one-size-fits-all' solution.
    Ivanov D; Hwang T; Sitko LK; Lee S; Gartner A
    Biochem Soc Trans; 2023 Jun; 51(3):1307-1317. PubMed ID: 37283472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validating the concept of mutational signatures with isogenic cell models.
    Zou X; Owusu M; Harris R; Jackson SP; Loizou JI; Nik-Zainal S
    Nat Commun; 2018 May; 9(1):1744. PubMed ID: 29717121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting presence of mutational signatures in cancer with confidence.
    Huang X; Wojtowicz D; Przytycka TM
    Bioinformatics; 2018 Jan; 34(2):330-337. PubMed ID: 29028923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The repertoire of mutational signatures in human cancer.
    Alexandrov LB; Kim J; Haradhvala NJ; Huang MN; Tian Ng AW; Wu Y; Boot A; Covington KR; Gordenin DA; Bergstrom EN; Islam SMA; Lopez-Bigas N; Klimczak LJ; McPherson JR; Morganella S; Sabarinathan R; Wheeler DA; Mustonen V; ; Getz G; Rozen SG; Stratton MR;
    Nature; 2020 Feb; 578(7793):94-101. PubMed ID: 32025018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational spectra and mutational signatures: Insights into cancer aetiology and mechanisms of DNA damage and repair.
    Phillips DH
    DNA Repair (Amst); 2018 Nov; 71():6-11. PubMed ID: 30236628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of mutational signatures in C. elegans: Implications for cancer genome analysis.
    Meier B; Volkova NV; Gerstung M; Gartner A
    DNA Repair (Amst); 2020 Nov; 95():102957. PubMed ID: 32980770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational signatures reveal ternary relationships between homologous recombination repair, APOBEC, and mismatch repair in gynecological cancers.
    Farmanbar A; Firouzi S; Kneller R; Khiabanian H
    J Transl Med; 2022 Feb; 20(1):65. PubMed ID: 35109853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering signatures of mutational processes operative in human cancer.
    Alexandrov LB; Nik-Zainal S; Wedge DC; Campbell PJ; Stratton MR
    Cell Rep; 2013 Jan; 3(1):246-59. PubMed ID: 23318258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MutSignatures: an R package for extraction and analysis of cancer mutational signatures.
    Fantini D; Vidimar V; Yu Y; Condello S; Meeks JJ
    Sci Rep; 2020 Oct; 10(1):18217. PubMed ID: 33106540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational tools to detect signatures of mutational processes in DNA from tumours: A review and empirical comparison of performance.
    Omichessan H; Severi G; Perduca V
    PLoS One; 2019; 14(9):e0221235. PubMed ID: 31513583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis.
    Petljak M; Alexandrov LB; Brammeld JS; Price S; Wedge DC; Grossmann S; Dawson KJ; Ju YS; Iorio F; Tubio JMC; Koh CC; Georgakopoulos-Soares I; Rodríguez-Martín B; Otlu B; O'Meara S; Butler AP; Menzies A; Bhosle SG; Raine K; Jones DR; Teague JW; Beal K; Latimer C; O'Neill L; Zamora J; Anderson E; Patel N; Maddison M; Ng BL; Graham J; Garnett MJ; McDermott U; Nik-Zainal S; Campbell PJ; Stratton MR
    Cell; 2019 Mar; 176(6):1282-1294.e20. PubMed ID: 30849372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two main mutational processes operate in the absence of DNA mismatch repair.
    Németh E; Lovrics A; Gervai JZ; Seki M; Rospo G; Bardelli A; Szüts D
    DNA Repair (Amst); 2020 May; 89():102827. PubMed ID: 32126497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Mutational Signatures Using the mutSignatures R Library.
    Fantini D; Meeks JJ
    Methods Mol Biol; 2023; 2684():45-57. PubMed ID: 37410227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The shaping of cancer genomes with the regional impact of mutation processes.
    Lee SY; Wang H; Cho HJ; Xi R; Kim TM
    Exp Mol Med; 2022 Jul; 54(7):1049-1060. PubMed ID: 35902761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatic Methods to Identify Mutational Signatures in Cancer.
    Islam SMA; Alexandrov LB
    Methods Mol Biol; 2021; 2185():447-473. PubMed ID: 33165866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of nucleotide excision repair is associated with mutational signature observed in cancer.
    Jager M; Blokzijl F; Kuijk E; Bertl J; Vougioukalaki M; Janssen R; Besselink N; Boymans S; de Ligt J; Pedersen JS; Hoeijmakers J; Pothof J; van Boxtel R; Cuppen E
    Genome Res; 2019 Jul; 29(7):1067-1077. PubMed ID: 31221724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.